NASDAQ:DRNA
Delisted

Dicerna Pharmaceuticals Stock Price (Quote)

$38.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $38.22 $38.22 Friday, 27th May 2022 DRNA stock ended at $38.22. During the day the stock fluctuated 0% from a day low at $38.22 to a day high of $38.22.
90 days $38.22 $38.22
52 weeks $19.06 $40.14

Historical Dicerna Pharmaceuticals prices

Date Open High Low Close Volume
Jan 22, 2016 $7.96 $8.06 $7.41 $7.94 60 800
Jan 21, 2016 $8.12 $8.95 $7.71 $7.78 74 000
Jan 20, 2016 $7.28 $8.36 $7.06 $8.07 158 800
Jan 19, 2016 $7.50 $7.56 $6.70 $7.44 161 800
Jan 15, 2016 $7.16 $7.40 $6.72 $7.37 99 100
Jan 14, 2016 $7.20 $7.79 $6.59 $7.44 95 100
Jan 13, 2016 $8.06 $8.24 $7.19 $7.20 115 500
Jan 12, 2016 $8.53 $9.11 $7.58 $8.00 128 200
Jan 11, 2016 $9.11 $9.27 $7.75 $8.31 134 000
Jan 08, 2016 $9.65 $9.83 $9.05 $9.09 154 300
Jan 07, 2016 $9.80 $9.91 $9.28 $9.56 232 100
Jan 06, 2016 $10.72 $10.74 $9.91 $10.04 148 200
Jan 05, 2016 $11.37 $11.66 $10.76 $10.85 135 400
Click to get the best stock tips daily for free!

About Dicerna Pharmaceuticals

Dicerna Pharmaceuticals Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary RNA interference technology platform in the United States and internationally. The company’s development programs include DCR-PH1 for the treatment of primary hyperoxaluria type 1 (PH1) through targeting the gene encoding the liver enzyme glycolate oxidase; and other rare inherit... DRNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT